Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- DOI
- 10.1056/nejmoa2022190
- Published
- 2020-10-08
- Container
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1056/nejmoa2022190,
title = {Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure},
author = {Milton Packer and Stefan D. Anker and Javed Butler and Gerasimos Filippatos and Stuart J. Pocock and Peter Carson and James Januzzi and Subodh Verma and Hiroyuki Tsutsui and Martina Brueckmann and Waheed Jamal and Karen Kimura and Janet Schnee and Cordula Zeller and Daniel Cotton and Edimar Bocchi and Michael Böhm and Dong-Ju Choi and Vijay Chopra and Eduardo Chuquiure and Nadia Giannetti and Stefan Janssens and Jian Zhang and Jose R. Gonzalez Juanatey and Sanjay Kaul and Hans-Peter Brunner-La Rocca and Bela Merkely and Stephen J. Nicholls and Sergio Perrone and Ileana Pina and Piotr Ponikowski and Naveed Sattar and Michele Senni and Marie-France Seronde and Jindrich Spinar and Iain Squire and Stefano Taddei and Christoph Wanner and Faiez Zannad},
year = {2020},
journal = {New England Journal of Medicine},
doi = {10.1056/nejmoa2022190},
url = {https://doi.org/10.1056/nejmoa2022190}
}RIS
TY - JOUR TI - Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure AU - Milton Packer AU - Stefan D. Anker AU - Javed Butler AU - Gerasimos Filippatos AU - Stuart J. Pocock AU - Peter Carson AU - James Januzzi AU - Subodh Verma AU - Hiroyuki Tsutsui AU - Martina Brueckmann AU - Waheed Jamal AU - Karen Kimura AU - Janet Schnee AU - Cordula Zeller AU - Daniel Cotton AU - Edimar Bocchi AU - Michael Böhm AU - Dong-Ju Choi AU - Vijay Chopra AU - Eduardo Chuquiure AU - Nadia Giannetti AU - Stefan Janssens AU - Jian Zhang AU - Jose R. Gonzalez Juanatey AU - Sanjay Kaul AU - Hans-Peter Brunner-La Rocca AU - Bela Merkely AU - Stephen J. Nicholls AU - Sergio Perrone AU - Ileana Pina AU - Piotr Ponikowski AU - Naveed Sattar AU - Michele Senni AU - Marie-France Seronde AU - Jindrich Spinar AU - Iain Squire AU - Stefano Taddei AU - Christoph Wanner AU - Faiez Zannad PY - 2020 JO - New England Journal of Medicine DO - 10.1056/nejmoa2022190 UR - https://doi.org/10.1056/nejmoa2022190 ER -
APA
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., Jamal, W., Kimura, K., Schnee, J., Zeller, C., Cotton, D., Bocchi, E., Böhm, M., Choi, D., Chopra, V., Chuquiure, E., Giannetti, N., Janssens, S., Zhang, J., Juanatey, J. R. G., Kaul, S., Rocca, H. B., Merkely, B., Nicholls, S. J., Perrone, S., Pina, I., Ponikowski, P., Sattar, N., Senni, M., Seronde, M., Spinar, J., Squire, I., Taddei, S., Wanner, C., & Zannad, F. (2020). Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2022190
Source records
- crossref · retrieved 2026-09-27T10:42:16.045Z